Pharmacotherapy for obesity: novel agents and paradigms

S Manning, A Pucci, N Finer - Therapeutic advances in …, 2014 - journals.sagepub.com
Public health initiatives focused on obesity prevention and lifestyle intervention programmes
for patients with obesity have struggled to contain the obesity epidemic to date. In recent …

Emerging pharmacotherapy for obesity

LJ Aronne, AG Powell, CM Apovian - Expert opinion on emerging …, 2011 - Taylor & Francis
Introduction: Obesity is a rapidly increasing global health problem. The rates of obesity have
tripled over the past three decades and are predicted to rise even further. The need for safe …

Future pharmacotherapy for obesity: new anti-obesity drugs on the horizon

G Srivastava, C Apovian - Current obesity reports, 2018 - Springer
Abstract Purpose of Review Obesity is a global health crisis with detrimental effects on all
organ systems leading to worsening disease state and rising costs of care. Persons with …

Recent advances in obesity pharmacotherapy

MA Mayer, C Hocht, A Puyó… - Current Clinical …, 2009 - ingentaconnect.com
Obesity is considered a worldwide epidemic. Weight reduction by means of lifestyle changes
is difficult to achieve, and pharmacotherapy is frequently needed. Although all currently …

Drug treatment of obesity: established and emerging therapies.

ML Isidro, F Cordido - Mini reviews in medicinal chemistry, 2009 - europepmc.org
Available anti-obesity pharmacotherapy options remain very limited. The development of
more effective drugs has become a priority. The potential strategies to achieve weight loss …

[HTML][HTML] Beyond weight loss: added benefits could guide the choice of anti-obesity medications

V Guglielmi, S Bettini, P Sbraccia, L Busetto… - Current obesity …, 2023 - Springer
Abstract Purpose of Review To highlight the added benefits of approved and upcoming,
centrally-acting, anti-obesity drugs, focusing not only on the most common metabolic and …

Current pharmacotherapeutic concepts for the treatment of obesity in adults

E Idelevich, W Kirch… - Therapeutic Advances in …, 2009 - journals.sagepub.com
Obesity is one of the greatest public health challenges of the twenty-first century. The World
Health Organization (WHO) reports that in 2005 approximately 1.6 billion adults were …

The obesity epidemic: current and future pharmacological treatments

KG Hofbauer, JR Nicholson… - Annu. Rev. Pharmacol …, 2007 - annualreviews.org
The unabated rise in the prevalence of obesity is a challenge for global health care systems.
Efforts to reverse this trend by dietary or behavioral counseling have not been successful …

[PDF][PDF] The challenge of obesity treatment: a review of approved drugs and new therapeutic targets

B Bonamichi, EB Parente, RB Dos Santos… - J Obes Eat …, 2018 - researchgate.net
Obesity is a metabolic dysfunction associated with a wide range of chronic illnesses that
cause significant increases in comorbidity and mortality. According to the World Health …

Updates on obesity pharmacotherapy

A Velazquez, CM Apovian - Annals of the New York Academy …, 2018 - Wiley Online Library
Obesity is a chronic, relapsing disease that necessitates a multidisciplinary approach to
management. Behavioral changes are the foundation to management, but adjunctive …